Scanlan Sean F. 4
4 · TREACE MEDICAL CONCEPTS, INC. · Filed Sep 16, 2024
Insider Transaction Report
Form 4
Scanlan Sean F.
Chief Innovation Officer
Transactions
- Exercise/Conversion
Stock Option (Right to Buy)
2024-09-12−33,750→ 0 totalExercise: $0.10From: 2018-12-15Exp: 2024-12-15→ Common Stock (33,750 underlying) - Exercise/Conversion
Common Stock
2024-09-12$0.10/sh+33,750$3,281→ 250,074 total
Footnotes (2)
- [F1]Includes 215,185 restricted stock units.
- [F2]The stock option vested in equal annual installments over 4 years, commencing on December 15, 2014 with the last installment vesting on December 15, 2018.